MBBS Year
1st Year
Subject
What Is Usually Asked
Cardiac output, Frank-Starling law, regulation of the heart
Congestive heart failure (CHF) is a clinical syndrome in which the heart cannot pump enough blood to meet the body's metabolic needs, or can do so only at raised filling pressures, leading to congestion of the lungs and systemic veins. It is examined in Physiology in 1st Year, Pathology and Pharmacology in 2nd Year, and General Medicine in Final Year.
| MBBS Year | Subject | What Is Usually Asked |
|---|---|---|
| 1st Year | Physiology | Cardiac output, Frank-Starling law, regulation of the heart |
| 2nd Year | Pathology | Pathophysiology, chronic venous congestion of lung and liver, cardiac hypertrophy |
| 2nd Year | Pharmacology | Drugs for heart failure, digoxin, diuretics |
| Final Year | General Medicine | Causes, clinical features, investigations, management, acute pulmonary oedema |
MBBS Year
1st Year
Subject
What Is Usually Asked
Cardiac output, Frank-Starling law, regulation of the heart
MBBS Year
2nd Year
Subject
What Is Usually Asked
Pathophysiology, chronic venous congestion of lung and liver, cardiac hypertrophy
MBBS Year
2nd Year
Subject
What Is Usually Asked
Drugs for heart failure, digoxin, diuretics
MBBS Year
Final Year
Subject
What Is Usually Asked
Causes, clinical features, investigations, management, acute pulmonary oedema
Definition: Heart failure is a clinical syndrome with symptoms and signs caused by a structural or functional cardiac abnormality, supported by raised natriuretic peptide levels or objective evidence of pulmonary or systemic congestion.
| Basis | Types |
|---|---|
| Ejection fraction | HFrEF (40% or less); HFmrEF (41 to 49%); HFpEF (50% or more) |
| Side mainly affected | Left-sided; right-sided; biventricular (congestive) |
| Onset | Acute; chronic; acute decompensation of chronic heart failure |
| Cardiac output | Low-output; high-output |
| Function | Systolic dysfunction; diastolic dysfunction |
Basis
Ejection fraction
Types
HFrEF (40% or less); HFmrEF (41 to 49%); HFpEF (50% or more)
Basis
Side mainly affected
Types
Left-sided; right-sided; biventricular (congestive)
Basis
Onset
Types
Acute; chronic; acute decompensation of chronic heart failure
Basis
Cardiac output
Types
Low-output; high-output
Basis
Function
Types
Systolic dysfunction; diastolic dysfunction
| Class | Symptoms |
|---|---|
| I | No limitation of ordinary physical activity |
| II | Slight limitation; ordinary activity causes symptoms |
| III | Marked limitation; less than ordinary activity causes symptoms |
| IV | Symptoms at rest; any activity increases discomfort |
Class
I
Symptoms
No limitation of ordinary physical activity
Class
II
Symptoms
Slight limitation; ordinary activity causes symptoms
Class
III
Symptoms
Marked limitation; less than ordinary activity causes symptoms
Class
IV
Symptoms
Symptoms at rest; any activity increases discomfort
| Category | Examples |
|---|---|
| Myocardial damage | Coronary artery disease and myocardial infarction, cardiomyopathies, myocarditis |
| Pressure overload | Hypertension, aortic stenosis |
| Volume overload | Mitral and aortic regurgitation |
| Valvular disease | Rheumatic heart disease |
| Arrhythmias | Atrial fibrillation, persistent tachyarrhythmias, complete heart block |
| Pericardial disease | Constrictive pericarditis, cardiac tamponade |
| Right heart failure | Secondary to left heart failure (most common), cor pulmonale, pulmonary hypertension |
| High-output failure | Severe anaemia, thyrotoxicosis, arteriovenous fistula, beriberi, Paget's disease of bone |
Category
Myocardial damage
Examples
Coronary artery disease and myocardial infarction, cardiomyopathies, myocarditis
Category
Pressure overload
Examples
Hypertension, aortic stenosis
Category
Volume overload
Examples
Mitral and aortic regurgitation
Category
Valvular disease
Examples
Rheumatic heart disease
Category
Arrhythmias
Examples
Atrial fibrillation, persistent tachyarrhythmias, complete heart block
Category
Pericardial disease
Examples
Constrictive pericarditis, cardiac tamponade
Category
Right heart failure
Examples
Secondary to left heart failure (most common), cor pulmonale, pulmonary hypertension
Category
High-output failure
Examples
Severe anaemia, thyrotoxicosis, arteriovenous fistula, beriberi, Paget's disease of bone
Natriuretic peptides (ANP and BNP) are released in response to stretch and partly counter these effects. Modern drug treatment works by blocking the harmful neurohormonal pathways.
(Examiner may ask you to draw the neurohormonal activation flowchart.)
Within limits, increased stretch of cardiac fibres (higher end-diastolic volume) increases the force of contraction. In failing hearts, the curve is flattened, so extra filling produces congestion rather than more output.
| Organ | Findings |
|---|---|
| Lung (left heart failure) | Congested alveolar capillaries, alveolar oedema, haemosiderin-laden macrophages ("heart failure cells"), brown induration in chronic cases |
| Liver (right heart failure) | Centrilobular congestion and necrosis giving a "nutmeg liver" appearance; cardiac sclerosis in long-standing cases |
| Heart | Hypertrophy (concentric in pressure overload, eccentric in volume overload) and dilatation |
Organ
Lung (left heart failure)
Findings
Congested alveolar capillaries, alveolar oedema, haemosiderin-laden macrophages ("heart failure cells"), brown induration in chronic cases
Organ
Liver (right heart failure)
Findings
Centrilobular congestion and necrosis giving a "nutmeg liver" appearance; cardiac sclerosis in long-standing cases
Organ
Heart
Findings
Hypertrophy (concentric in pressure overload, eccentric in volume overload) and dilatation
| Left Heart Failure (Pulmonary Congestion) | Right Heart Failure (Systemic Congestion) |
|---|---|
| Breathlessness on exertion | Raised jugular venous pressure |
| Orthopnoea | Tender hepatomegaly |
| Paroxysmal nocturnal dyspnoea | Dependent pitting oedema |
| Cough with frothy sputum in pulmonary oedema | Ascites and pleural effusion |
| Basal crackles | Positive hepatojugular reflux |
| Third heart sound (gallop rhythm) | Anorexia and abdominal discomfort from gut congestion |
| Pulsus alternans in severe disease | - |
Left Heart Failure (Pulmonary Congestion)
Breathlessness on exertion
Right Heart Failure (Systemic Congestion)
Raised jugular venous pressure
Left Heart Failure (Pulmonary Congestion)
Orthopnoea
Right Heart Failure (Systemic Congestion)
Tender hepatomegaly
Left Heart Failure (Pulmonary Congestion)
Paroxysmal nocturnal dyspnoea
Right Heart Failure (Systemic Congestion)
Dependent pitting oedema
Left Heart Failure (Pulmonary Congestion)
Cough with frothy sputum in pulmonary oedema
Right Heart Failure (Systemic Congestion)
Ascites and pleural effusion
Left Heart Failure (Pulmonary Congestion)
Basal crackles
Right Heart Failure (Systemic Congestion)
Positive hepatojugular reflux
Left Heart Failure (Pulmonary Congestion)
Third heart sound (gallop rhythm)
Right Heart Failure (Systemic Congestion)
Anorexia and abdominal discomfort from gut congestion
Left Heart Failure (Pulmonary Congestion)
Pulsus alternans in severe disease
Right Heart Failure (Systemic Congestion)
-
General features: Fatigue, reduced exercise tolerance, weight gain from fluid retention, cool peripheries and cardiac cachexia in advanced disease.
Heart failure is diagnosed with two major criteria, or one major and two minor criteria.
| Major Criteria | Minor Criteria |
|---|---|
| Paroxysmal nocturnal dyspnoea | Bilateral ankle oedema |
| Neck vein distension | Nocturnal cough |
| Crackles | Breathlessness on ordinary exertion |
| Cardiomegaly on X-ray | Hepatomegaly |
| Acute pulmonary oedema | Pleural effusion |
| Third heart sound gallop | Reduced vital capacity |
| Raised central venous pressure | Tachycardia |
| Hepatojugular reflux | - |
| Weight loss in response to treatment | - |
Major Criteria
Paroxysmal nocturnal dyspnoea
Minor Criteria
Bilateral ankle oedema
Major Criteria
Neck vein distension
Minor Criteria
Nocturnal cough
Major Criteria
Crackles
Minor Criteria
Breathlessness on ordinary exertion
Major Criteria
Cardiomegaly on X-ray
Minor Criteria
Hepatomegaly
Major Criteria
Acute pulmonary oedema
Minor Criteria
Pleural effusion
Major Criteria
Third heart sound gallop
Minor Criteria
Reduced vital capacity
Major Criteria
Raised central venous pressure
Minor Criteria
Tachycardia
Major Criteria
Hepatojugular reflux
Minor Criteria
-
Major Criteria
Weight loss in response to treatment
Minor Criteria
-
| Investigation | Purpose or Findings |
|---|---|
| Echocardiography | Key test: ejection fraction, chamber size, wall motion, valve disease, pericardial disease |
| BNP or NT-proBNP | Raised in heart failure; a normal level makes heart failure unlikely |
| ECG | Ischaemia, previous infarction, hypertrophy, arrhythmias such as atrial fibrillation |
| Chest X-ray | Cardiomegaly (cardiothoracic ratio above 0.5), upper lobe venous diversion, Kerley B lines, "bat-wing" perihilar shadowing, pleural effusion |
| Blood tests | Complete blood count (anaemia), renal function, electrolytes, liver function, thyroid function, glucose, lipids |
| Coronary angiography | When ischaemic heart disease is suspected |
Investigation
Echocardiography
Purpose or Findings
Key test: ejection fraction, chamber size, wall motion, valve disease, pericardial disease
Investigation
BNP or NT-proBNP
Purpose or Findings
Raised in heart failure; a normal level makes heart failure unlikely
Investigation
ECG
Purpose or Findings
Ischaemia, previous infarction, hypertrophy, arrhythmias such as atrial fibrillation
Investigation
Chest X-ray
Purpose or Findings
Cardiomegaly (cardiothoracic ratio above 0.5), upper lobe venous diversion, Kerley B lines, "bat-wing" perihilar shadowing, pleural effusion
Investigation
Blood tests
Purpose or Findings
Complete blood count (anaemia), renal function, electrolytes, liver function, thyroid function, glucose, lipids
Investigation
Coronary angiography
Purpose or Findings
When ischaemic heart disease is suspected
| Drug Class | Examples | Key Points |
|---|---|---|
| ACE inhibitors, ARBs or ARNI | Enalapril, ramipril; losartan; sacubitril-valsartan | Reduce mortality; monitor potassium and renal function |
| Beta-blockers | Carvedilol, bisoprolol, metoprolol succinate | Reduce mortality; start low and increase slowly when stable |
| Mineralocorticoid receptor antagonists | Spironolactone, eplerenone | Reduce mortality; risk of hyperkalaemia; gynaecomastia with spironolactone |
| SGLT2 inhibitors | Dapagliflozin, empagliflozin | Reduce hospitalisation and death, in patients with or without diabetes |
Drug Class
ACE inhibitors, ARBs or ARNI
Examples
Enalapril, ramipril; losartan; sacubitril-valsartan
Key Points
Reduce mortality; monitor potassium and renal function
Drug Class
Beta-blockers
Examples
Carvedilol, bisoprolol, metoprolol succinate
Key Points
Reduce mortality; start low and increase slowly when stable
Drug Class
Mineralocorticoid receptor antagonists
Examples
Spironolactone, eplerenone
Key Points
Reduce mortality; risk of hyperkalaemia; gynaecomastia with spironolactone
Drug Class
SGLT2 inhibitors
Examples
Dapagliflozin, empagliflozin
Key Points
Reduce hospitalisation and death, in patients with or without diabetes
| Treatment | Role |
|---|---|
| Loop diuretics (furosemide) | Relieve congestion and oedema; no survival benefit |
| Digoxin | Symptom control and rate control in atrial fibrillation; narrow therapeutic index |
| Ivabradine | Selected patients in sinus rhythm with a high heart rate |
| Hydralazine with isosorbide dinitrate | Selected patients, such as those unable to take ACE inhibitors or ARBs |
| Implantable cardioverter-defibrillator | Prevention of sudden cardiac death in selected patients |
| Cardiac resynchronisation therapy | Selected patients with a wide QRS complex |
| Heart transplantation | End-stage heart failure |
Treatment
Loop diuretics (furosemide)
Role
Relieve congestion and oedema; no survival benefit
Treatment
Digoxin
Role
Symptom control and rate control in atrial fibrillation; narrow therapeutic index
Treatment
Ivabradine
Role
Selected patients in sinus rhythm with a high heart rate
Treatment
Hydralazine with isosorbide dinitrate
Role
Selected patients, such as those unable to take ACE inhibitors or ARBs
Treatment
Implantable cardioverter-defibrillator
Role
Prevention of sudden cardiac death in selected patients
Treatment
Cardiac resynchronisation therapy
Role
Selected patients with a wide QRS complex
Treatment
Heart transplantation
Role
End-stage heart failure
Heart failure carries a high risk of hospitalisation and death, especially in advanced NYHA classes. Guideline-directed drug therapy, device therapy where indicated and treatment of the underlying cause substantially improve symptoms and survival.
Q: What are heart failure cells? A: Haemosiderin-laden macrophages in the alveoli, seen in chronic left heart failure.
Q: What is the commonest cause of right heart failure? A: Left heart failure.
Q: Why does orthopnoea occur? A: Lying flat increases venous return to the heart and lungs, worsening pulmonary congestion.
Q: What are Kerley B lines? A: Short horizontal lines at the lung bases on chest X-ray, indicating interstitial oedema.
Q: How does digoxin act? A: It inhibits the Na+/K+ ATPase, increasing intracellular calcium and contractility; hypokalaemia increases its toxicity.
Typical question styles (not attributed to specific papers or years):
Left heart failure causes pulmonary congestion with breathlessness, orthopnoea and crackles. Right heart failure causes systemic venous congestion with raised JVP, hepatomegaly and dependent oedema. The most common cause of right heart failure is left heart failure.
ACE inhibitors, ARBs or sacubitril-valsartan; evidence-based beta-blockers; mineralocorticoid receptor antagonists; and SGLT2 inhibitors. Loop diuretics relieve symptoms but do not reduce mortality.
Yes. Use the Download PPT button at the top of this page. The GeckoMed app also gives offline access to the slides and notes.
Try Gecko Med
Revise high-yield topics, solve previous year questions, and keep your MBBS prep moving in one place.